Concepedia

Publication | Closed Access

Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer

DOI

33

Citations

25

References

2014

Year

Howard S. Höchster, Nataliya V. Uboha, Wells A. Messersmith, Philip J. Gold, Bert H. O’Neil, Deirdre Jill Cohen, Crystal S. Denlinger, S. Cohen, Cynthia G. Leichman, Lawrence Leichman
Cancer Chemotherapy and Pharmacology

References

YearCitations

Page 1